Vectors Research Management, LLC Organon & Co. Transaction History

Vectors Research Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$31.66 - $38.9 $189 - $233	6 Added 2.55%	241 $8,000
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $40,224 - $51,994	-1,321 Reduced 84.9%	235 $8,000
Q4 2021 Feb 15, 2022	SELL	$28.67 - $37.13 $602 - $779	-21 Reduced 1.33%	1,556 $47,000
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $1,288 - $1,603	45 Added 2.94%	1,577 $52,000
Q2 2021 Aug 09, 2021	BUY	$28.45 - $38.0 $43,585 - $58,216	1,532 New	1,532 $46,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vectors Research Management, LLC with notifications on news.